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background: Psoriasis (PSO), a systemic inflammatory disorder, is associated with increased susceptibility to cardiovascular disease (CVD), 
and circulating blood monocytes are thought to play a role. Monocytes are considered to be a heterogeneous population, and while the CD16- 
classical monocytic subset has been associated with early atherosclerosis, the role of CD16+ subsets is unclear. The current study utilized 
18-Flurodeoxyglucose (FDG)-positron emission tomography (PET) computed tomography (CT) imaging, a reliable indicator of vascular inflammation, 
atherosclerotic plaque activity and future CV events, along with flow cytometry to evaluate the relationship between vascular inflammation and 
monocytic subsets in PSO.
methods: In vivo vascular inflammation, defined by maximum standardized uptake value (SUV) in the aorta, was measured by FDG-PET/CT in PSO 
patients (n=26). Monocytic subsets were evaluated based on differential expression of CD14 and CD16 in the peripheral whole blood: classical 
(CD14++CD16-), intermediate (CD14++CD16+), and nonclassical (CD14+CD16++). After adjusting for traditional CVD risk factors, demographics, 
HDL efflux and BMI, the relationship between monocytic subsets and aortic vascular inflammation was determined using linear regression analysis.
results: FDG-PET/CT imaging demonstrated vascular inflammation in the aorta that significantly correlated with total monocyte count (β=0.26, 
p<0.01), classical (β=0.02, p<0.01), intermediate (β=-0.30, p<0.01), and nonclassical subsets (β=0.22, p<0.01). In opposition to the other 
subpopulations, an increase in the intermediate subset was associated with decreased aortic vascular inflammation. These findings were supported 
by the classical: intermediate (β=0.06, p<0.01), nonclassical: intermediate (β=0.61, p<0.01), and classical: nonclassical ratios (β=-0.05, p<0.01).
conclusions: Total monocyte count as well as all three monocytic subsets independently predict aortic vascular inflammation beyond traditional 
risk factors in PSO. For the first time, we demonstrate that CD16+ cell populations may have relevance in CVD, and that intermediate monocytes may 
protect from CVD.
